Tag: Medical

Cardiawave
Europe

Cardiawave appoints Olivier Pierron as its Chief Executive Officer

LEVALLOIS-PERRET, France – Cardiawave SA, a French Medtech company that has developed an innovative Non-Invasive Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis, is delighted to announce the appointment of Olivier Pierron as its new Chief Executive Officer. With more than 25 years of experience in cardiovascular therapies and a passion for innovation, Olivier Pierron brings to Cardiawave invaluable expertise … Continue reading Cardiawave appoints Olivier Pierron as its Chief Executive Officer

Impact Newswire
Miach Orthopaedics
United States

Miach Orthopaedics Raises $20 Million in Series B Extension

The Major League Soccer Players Association (MLSPA), SV Health Investors and Aperture Venture Partners Join Existing Investors to Support Commercial Expansion and Clinical Activities for BEAR® Implant WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing … Continue reading Miach Orthopaedics Raises $20 Million in Series B Extension

Impact Newswire
Myomo
United States

Myomo Appoints Heather Getz to its Board of Directors

BOSTON–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. … Continue reading Myomo Appoints Heather Getz to its Board of Directors

Impact Newswire
Lucas Vitale
United States

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

March 18, 2024 07:00 AM Eastern Daylight Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer. “I look forward to being a part of the team that will help further advance the company as we focus on continuous improvements … Continue reading Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Impact Newswire
Vivani
Global, United States

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured in 2012 approval of Bydureon® (exenatide injection), the world’s first once-weekly GLP-1 receptor agonist, a class of drugs that now includes blockbusters Ozempic®, Trulicity®, and Wegovy® ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or … Continue reading Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Impact Newswire
Cagent Vascular
Global, United States

Cagent Vascular Raises $30 Million Series C Financing

Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new investor Blue Ridge Medical, LLC and existing investors, … Continue reading Cagent Vascular Raises $30 Million Series C Financing

Impact Newswire
QuidelOrtho
Global, United States

QuidelOrtho Announces Changes in Executive Leadership

The Board of Directors has terminated President and Chief Executive Officer, Douglas Bryant and appointed, on an interim basis, Michael Iskra as Chief Executive Officer and Robert Bujarski as President SAN DIEGO–(BUSINESS WIRE)–The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value. “All of … Continue reading QuidelOrtho Announces Changes in Executive Leadership

Impact Newswire
MMI (MEDICAL MICROINSTRUMENTS, INC.)
Europe, Global

MMI Raises $110 Million in Series C Financing

Largest ever investment in microsurgery will further MMI’s mission to transform open surgery with robotic technology JACKSONVILLE, Fla.–(BUSINESS WIRE)–MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing. The round, led by Fidelity Management & Research Company, marks the largest ever investment in … Continue reading MMI Raises $110 Million in Series C Financing

Impact Newswire
Amplitude Vascular Systems
Global, United States

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Impact Newswire